[A comparative chemoreactome analysis of mexidol]
I Yu Torshin1, O A Gromova2, I S Sardaryan2
1Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
Summary
Mexidol demonstrates a broad therapeutic potential, acting as an agonist, anti-inflammatory, neurotrophic, and hypolipidemic agent. It exhibits a superior safety profile compared to other molecules, offering a promising therapeutic option.
Area of Science:
- Pharmacology and Cheminformatics
- Molecular Modeling
- Drug Discovery
Background:
- Mexidol is a drug with established therapeutic uses.
- Understanding its precise molecular mechanisms and comparing it to other agents is crucial for optimizing its application.
- Chemoreactome analysis provides a novel approach to predict drug-target interactions and pharmacological effects.
Purpose of the Study:
- To compare the molecular interactions of Mexidol with control drugs (choline alfoscerate, piracetam, glycine, semax) using chemoreactome analysis.
- To elucidate the potential pharmacological activities and safety profile of Mexidol at a molecular level.
- To model the human metabolome and predict Mexidol's interactions within this system.
Main Methods:
- Chemoreactome analysis was employed to compare Mexidol's chemical structure against metabolites from the Human Metabolome Database (HMDB) and a drug database.
- Over 40,000 metabolites from HMDB were utilized to model the human metabolome.
- In silico methods were used to predict drug-receptor interactions and potential pharmacological effects.
Main Results:
- Mexidol was predicted to act as an agonist for acetylcholine and GABA-A receptors.
- It is suggested to possess anti-inflammatory properties by inhibiting prostaglandin synthesis.
- Mexidol demonstrated potential as a neurotrophic, neuroprotective, coagulation inhibitor, anti-diabetic, and hypolipidemic agent.
- Compared to control molecules, Mexidol showed a more favorable safety profile, with less impact on serotonin, dopamine, adrenergic receptors, cardiac potassium channels, MAO, and P450 cytochromes.
Conclusions:
- Chemoreactome analysis provides valuable insights into Mexidol's multifaceted molecular mechanisms of action.
- Mexidol exhibits a broad spectrum of potential therapeutic activities and a favorable safety profile.
- These findings support further investigation into Mexidol's clinical applications and mechanism-based drug design.
More Related Videos
05:35An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
Published on: September 20, 2022
4.3K
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
10.4K
